Table 3.

Previous treatment lines

Previous lines	N	Treatment
1	7	First: ABVD (n=6/7) ABVD + ASCT (n=1/7)
2	8	First: ABVD Second: ESHAP (n=3/8) ESHAP + ASCT (n=4/8) DHAP (n=1/8)
3	6	First: ABVD Second: ABVD (n=1/6) ESHAP (n=1/6) MOPP (n=1/6) DHAP (n=2/6) BEACOPP (n=1/6) Third: IFE (n=1/6) ESHAP (n=3/6) + ASCT (n=1/6) RT (n=2/6) + ASCT (n=1/5)
4	2	First: ABVD (n=1/2) CHOP (n=1/2) Second: DHAP + ASCT (n=1/2) HyperCVAD (n=1/2) Third: IFE (n=1/2) ESHAP + ASCT (n=1/2) Fourth: methotrexate + vincristine (n=1/2) ABVD (n=1/2)
6	1	First: ABVD Second: MOPP Third: ESHAP + ASCT Fourth: vinblastine/procarbazine/cyclophosphamide/prednisone Fifth: RT Sixth: MINE

Abbreviations: N, total number; ABVD, adriamycin, bleomycin, vinblastine, dacarbazine; n, sample number; ASCT, autologous stem cell transplantation; ESHAP, etoposide, cisplatin, cytarabine, methylprednisolone; DHAP, cisplatin, cytarabine, dexamethasone; MOPP, nitrogen mustard, vincristine, procarbazine, prednisone; BEACOPP, bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone; IFE, ifosfamide, etoposide; RT, radiotherapy; HyperCVAD, cyclophosphamide, vincristine, adriamycin, dexamethasone; MINE, mesna, ifosfamide, mitoxantrone, etoposide; CHOP, cyclophosphamide, vincristine, adriamycin, prednisone.